Article
Peripheral metabolic-redox signaling as a core mechanism of major depressive disorder: evidence from deep metabolomic phenotyping.
Acta neuropsychiatrica - 24 Feb 2026
Maes Michael, Niu Mengqi, Maes Annabel, Luo Yiping, Yangyang Chenkai, Almulla Abbas F, Li Jing, Zhang Yingqian
Abstract excerpt
BACKGROUND: Major depressive disorder (MDD) is a neuro-immune, oxidative, and nitrosative stress (NIMETOX) disorder, in which peripheral immune-redox pathways intersect with metabolic networks leading to neurotoxicity within the limbic-prefrontal affective circuits. Comprehensive metabolomics analysis in well-phenotyped patients is vital to elucidate their metabolic profile. OBJECTIVES: To identify metabolic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
